Modulation of pro and anti-inflammatory cytokine expression by CCR5+ cells in experimental periodontal disease

• Grant number: 07/00719-4
• Support Opportunities: Scholarships in Brazil - Scientific Initiation
• Effective date (Start): May 01, 2007
• Effective date (End): April 30, 2009
• Field of knowledge: Health Sciences - Dentistry - Periodontology
• Principal Investigator: Gustavo Pompermaier Garlet
• Grantee: Isabela Sousa Nunes
• Host Institution: Faculdade de Odontologia de Bauru (FOB). Universidade de São Paulo (USP). Bauru , SP, Brazil

Abstract

Periodontal diseases are trigerred by putative Gram-negative periodontopathogens, such as Actinobacillus actinomycetemcomitans. The host responses to periodontopathogens are thought to be protective against infection, but may trigger periodontal destruction. The disease outcome is determined by the nature of host inflammatory and immune reaction, which involves the participation of several cell types and mediators. Inflammatory cytokines, chemokines and their receptors are thought to be involved in the recruitment of leukocytes to the periodontium. However, the exact mechanisms involved in mediate resistance or susceptibility to periodontitis development are not kwon. Previous studies demonstrate the presence of CCR5+ cells in periodontal lesions of humans, as well in the tissues of mouse, in our experimental model. Furthermore, the presence of CCR5+ cells presents positive correlations with high levels of RANKL. In this project, we will evaluate the role of CCR5+ cells in the outcome of experimental periodontal disease induced by A. actinomycetemcomitans in mice evaluating the modulation of pro- and anti-inflammatory cytokines expression by means of RealTimePCR. To our aims, the mice from the experimental groups will be evaluated regarding the disease severity, trough the quantification of alveolar bone loss and of the inflammatory infiltrate. Taken together, these data will contribute to the knowledge of role of immune responses to the outcome of periodontal diseases, and may provide the basis for future therapeutic interventions aimed at limiting the inflammatory process in these pathologies.